Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johanna Oechtering

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|February 21, 2022
Determination of CSF GFAP, CCN5, and vWF Levels Enhances the Diagnostic Accuracy of Clinically Defined MS From Non-MS Patients With CSF Oligoclonal BandsFay Probert, Tianrong Yeo, Yifan Zhou, et al.
Brain Communications|May 17, 2021
Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosisFay Probert, Tianrong Yeo, Yifan Zhou, et al.
Frontiers in Immunology|December 30, 2022
Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bandsFay Probert, Tianrong Yeo, Yifan Zhou, et al.
Multiple Sclerosis and Related Disorders|October 8, 2020
The weak association between neurofilament levels at multiple sclerosis onset and cognitive performance after 9 yearsLucie Friedova, Jiri Motyl, Barbora Srpova, et al.
Neurology|September 11, 2019
Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosisCatherina Pfuhl, Ulrike Grittner, René M Gieß, et al.
Journal of Neuroimmunology|July 23, 2015
Association of serum Epstein-Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosisCatherina Pfuhl, Johanna Oechtering, Ludwig Rasche, et al.
BMJ Neurology Open|April 18, 2025
Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosisDaniel E Radford-Smith, Abi G Yates, Tereza Kacerova, et al.
Communications Medicine|February 25, 2026
Serum GFAP and NfL augment a metabolomics-driven strategy for long-term prediction of multiple sclerosis progressionTereza Kacerova, Eline Willemse, Johanna Oechtering, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 8, 2020
Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosisTomas Uher, Mason McComb, Shery Galkin, et al.
Journal of Neurology|June 10, 2025
Retinal neuronal loss and progression independent of relapse activity in multiple sclerosisFederico Burguet Villena, Nuria Cerdá-Fuertes, Lisa Hofer, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|February 21, 2022
Determination of CSF GFAP, CCN5, and vWF Levels Enhances the Diagnostic Accuracy of Clinically Defined MS From Non-MS Patients With CSF Oligoclonal BandsFay Probert, Tianrong Yeo, Yifan Zhou, et al.
Brain Communications|May 17, 2021
Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosisFay Probert, Tianrong Yeo, Yifan Zhou, et al.
Frontiers in Immunology|December 30, 2022
Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bandsFay Probert, Tianrong Yeo, Yifan Zhou, et al.
Multiple Sclerosis and Related Disorders|October 8, 2020
The weak association between neurofilament levels at multiple sclerosis onset and cognitive performance after 9 yearsLucie Friedova, Jiri Motyl, Barbora Srpova, et al.
Neurology|September 11, 2019
Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosisCatherina Pfuhl, Ulrike Grittner, René M Gieß, et al.
Journal of Neuroimmunology|July 23, 2015
Association of serum Epstein-Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosisCatherina Pfuhl, Johanna Oechtering, Ludwig Rasche, et al.
BMJ Neurology Open|April 18, 2025
Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosisDaniel E Radford-Smith, Abi G Yates, Tereza Kacerova, et al.
Communications Medicine|February 25, 2026
Serum GFAP and NfL augment a metabolomics-driven strategy for long-term prediction of multiple sclerosis progressionTereza Kacerova, Eline Willemse, Johanna Oechtering, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 8, 2020
Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosisTomas Uher, Mason McComb, Shery Galkin, et al.
Journal of Neurology|June 10, 2025
Retinal neuronal loss and progression independent of relapse activity in multiple sclerosisFederico Burguet Villena, Nuria Cerdá-Fuertes, Lisa Hofer, et al.
Pageof 6